High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: The MEGA study

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 6, 2014, Pages 839-846

  Debeij, J ^a   van Zaane, B ^b,c   Dekkers, O M ^a   Doggen, C J M ^a,d   Smit, J W A ^a   van Zanten, A P ^b   Brandjes, D P M ^b,c   Buller H R ^c   Gerdes, V E A ^b,c   Rosendaal, F R ^a   Cannegieter, S C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Coagulation factors; Epidemiology; Thrombosis; Thyroid stimulating hormone; Thyroxine

Indexed keywords

ANTITHROMBIN; ANTITHYROID AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; FIBRINOGEN; LEVOTHYROXINE; PROTEIN C; PROTEIN S; PROTHROMBIN; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VEIN THROMBOSIS; ADOLESCENT; BLOOD; BLOOD CLOTTING; CASE CONTROL STUDY; CLINICAL TRIAL; EPIDEMIOLOGY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UPREGULATION; VENOUS THROMBOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; THYROXINE; UP-REGULATION; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84902096063     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12573     Document Type: Article

References (36)

1. Kaliebe H. Autochthone Sinusthrombose bei einem Falle von Morbus Basedow und Tabes. Med Klinik 1913; 9: 1929-32.
2. Squizzato A, Gerdes VE, Brandjes DP, Büller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 2005; 36: 2302-10.
3. De Schryver EL, Hoogenraad TU, Banga JD, Kappelle LJ. Thyrotoxicosis, protein C deficiency and lupus anticoagulant in a case of cerebral sinus thrombosis. Neth J Med 1999; 55: 201-2.
4. Molloy E, Cahill M, O'Hare JA. Cerebral venous sinus thrombosis precipitated by Graves' disease and Factor V Leiden mutation. Ir Med J 2003; 96: 46-7.
5. Mouton S, Nighoghossian N, Berruyer M, Derex L, Philippeau F, Cakmak S, Honnorat J, Hermier M, Trouillas P. Hyperthyroidism and cerebral venous thrombosis. Eur Neurol 2005; 54: 78-80.
6. Pekdemir M, Yilmaz S, Ersel M, Sarisoy HT. A rare cause of headache: cerebral venous sinus thrombosis due to hyperthyroidism. Am J Emerg Med 2008; 26: 383-3.
7. Siegert CE, Smelt AH, de Bruin TW. Superior sagittal sinus thrombosis and thyrotoxicosis. Possible association in two cases. Stroke 1995; 26: 496-7.
8. Squizzato A, Romualdi E, Büller HR, Gerdes VE. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 2007; 92: 2415-20.
9. Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997; 136: 1-7.
10. Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007; 92: 3006-12.
11. Erem C, Ersoz HO, Karti SS, Ukinc K, Hacihasanoglu A, Deger O, Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002; 25: 345-50.
12. Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 2005; 152: 355-61.
13. Michiels JJ, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001; 7: 113-15.
14. van Zaane B, Squizzato A, Huijgen R, van Zanten AP, Fliers E, Cannegieter SC, Büller HR, Gerdes VE, Brandjes DP. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood 2010; 115: 4344-9.
15. Debeij J, Dekkers OM, Asvold BO, Christiansen SC, Naess IA, Hammerstrom J, Rosendaal FR, Cannegieter SC. Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study. J Thromb Haemost 2012; 10: 1539-46.
16. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-22.
17. van Stralen KJ, Rosendaal FR, Doggen CJ. Minor injuries as a risk factor for venous thrombosis. Arch Intern Med 2008; 168: 21-6.
18. Franchini M. Hemostatic changes in thyroid diseases: haemostasis and thrombosis. Hematology 2006; 11: 203-8.
19. Debeij J, Cannegieter SC, van Zaane B, Smit JWA, Corssmit EPM, Rosendaal FR, Romijn JA, Dekkers OM. The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system. J Thromb Haemost 2010; 8: 2823-6.
20. Yango J, Alexopoulou O, Eeckhoudt S, Hermans C, Daumerie C. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy. Eur J Endocrinol 2011; 164: 599-603.
21. Squizzato A, Gerdes VE, Ageno W, Büller HR. The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med 2007; 2: 76-83.
22. Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, Rice KM, Lumley T. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009; 7: 263-9.
23. Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD, Folsom AR. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007; 5: 1455-61.
24. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 1995; 345: 152-5.
25. Ruiz-Sáez A. Thrombosis in rare bleeding disorders. Hematology 2012; 17(Suppl. 1): S156-8.
26. Lin HC, Yang LY, Kang JH. Increased risk of pulmonary embolism among patients with hyperthyroidism: a 5-year follow-up study. J Thromb Haemost 2010; 8: 2176-81.
27. Maes M, Mommen K, Hendrickx D, Peeters D, D'Hondt P, Ranjan R, De Meyer F, Scharpé S. Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers. Clin Endocrinol 1997; 46: 587-98.
28. Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O'Leary PC, Walsh JP. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012; 97: 1554-62.
29. Woodhams B, Girardot O, Blanco MJ, Colesse G, Gourmelin Y. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis 2001; 12: 229-36.
30. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 2004; 145: 2804-14.
31. Lin KH, Lee HY, Shih CH, Yen CC, Chen SL, Yang RC, Wang CS. Plasma protein regulation by thyroid hormone. J Endocrinol 2003; 179: 367-77.
32. Baumgartner-Parzer SM, Wagner L, Reining G, Sexl V, Nowotny P, Muller M, Brunner M, Waldhausl W. Increase by tri-iodothyronine of endothelin-1, fibronectin and von Willebrand factor in cultured endothelial cells. J Endocrinol 1997; 154: 231-9.
33. Franchini M, Lippi G, Manzato F, Vescovi PP. Thyroid-associated autoimmune coagulation disorders. J Thromb Thrombolysis 2010; 29: 87-91.
34. Hoylaerts MF, Thys C, Arnout J, Vermylen J. Recurrent arterial thrombosis linked to autoimmune antibodies enhancing von Willebrand factor binding to platelets and inducing Fc gamma RII receptor-mediated platelet activation. Blood 1998; 91: 2810-17.
35. Takamura N, Akilzhanova A, Hayashida N, Kadota K, Yamasaki H, Usa T, Nakazato M, Maeda T, Ozono Y, Aoyagi K. Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. Atherosclerosis 2009; 204: e77-81.
36. Hooper JMW, Stuijver DJF, Orme SM, van Zaane B, Hess K, Gerdes VE, Phoenix F, Rice P, Smith KA, Alzahrani SH, Standeven KF, Ajjan RA. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals. J Clin Endocrinol Metab 2012; 97: 1463-73.